Congratulations to Mortiz Gogl whose paper “DoseSurv: Predicting Personalized Survival Outcomes under Continuous-Valued Treatments” was accepted for NeurIPS 2025. A copy of the paper can be found on the NeurIPS25 website.
The early detection of diseases is a highly desirable approach for addressing conditions where late stage disease cannot be easily treated or managed. Through early detection, it may be possible to take actions to minimise future disease severity or even prevent disease occurrence altogether. However, while the general concept is readily accepted, putting early detection into practice is often far from straightforward.